Page 225 - Read Online

Page 8 of 10 Sahulee et al. Vessel Plus 2022;6:5 https://dx.doi.org/10.20517/2574-1209.2021.94

DECLARATIONS
Authors’ contributions
Contributed to the creation, authorship, review and approval of this article: Sahulee R, McKinstry J

Availability of data and materials
Not applicable.

Financial support and sponsorship
None.

Conflicts of interest
Both authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
The authors consent to the publication of this material.

Copyright
© The Author(s) 2022.

REFERENCES
1. Wessel DL. Managing low cardiac output syndrome after congenital heart surgery. Crit Care Med 2001;29:S220-30. DOI PubMed
2. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-54. DOI
PubMed
3. Kozik DJ, Tweddell JS. Characterizing the inflammatory response to cardiopulmonary bypass in children. Ann Thorac Surg
2006;81:S2347-54. DOI PubMed
4. Aĝirbaşli M, Nguyen ML, Win K, et al. Inflammatory and hemostatic response to cardiopulmonary bypass in pediatric population:
feasibility of seriological testing of multiple biomarkers. Artif Organs 2010;34:987-95. DOI PubMed
5. Mcguinness J, Bouchier-hayes D, Redmond J. Understanding the inflammatory response to cardiac surgery. Surgeon 2008;6:162-71.
DOI PubMed
6. Ramaswamy V, Horton J, Vandermeer B, Buscemi N, Miller S, Yager J. Systematic review of biomarkers of brain injury in term
neonatal encephalopathy. Pediatr Neurol 2009;40:215-26. DOI PubMed
7. Epting CL, McBride ME, Wald EL, Costello JM. Pathophysiology of post-operative low cardiac output syndrome. Curr Vasc
Pharmacol 2016;14:14-23. DOI PubMed
8. Bautista-Hernandez V, Karamanlidis G, McCully JD, Del Nido PJ. Cellular and molecular mechanisms of low cardiac output
syndrome after pediatric cardiac surgery. Curr Vasc Pharmacol 2016;14:5-13. DOI PubMed
9. Parr GV, Blackstone EH, Kirklin JW. Cardiac performance and mortality early after intracardiac surgery in infants and young children.
Circulation 1975;51:867-74. DOI PubMed
10. Wernovsky G, Wypij D, Jonas RA, et al. Postoperative course and hemodynamic profile after the arterial switch operation in neonates
and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation 1995;92:2226-35. DOI PubMed
11. Hoffman TM, Wernovsky G, Atz AM, et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and
children after corrective surgery for congenital heart disease. Circulation 2003;107:996-1002. DOI PubMed
12. Du X, Chen H, Song X, et al. Risk factors for low cardiac output syndrome in children with congenital heart disease undergoing
cardiac surgery: a retrospective cohort study. BMC Pediatr 2020;20:87. DOI PubMed PMC
13. Ulate KP, Yanay O, Jeffries H, Baden H, Di Gennaro JL, Zimmerman J. An elevated low cardiac output syndrome score is associated
with morbidity in infants after congenital heart surgery. Pediatr Crit Care Med 2017;18:26-33. DOI PubMed
14. Roeleveld PP, de Klerk JCA. The perspective of the intensivist on inotropes and postoperative care following pediatric heart surgery:
an international survey and systematic review of the literature. World J Pediatr Congenit Heart Surg 2018;9:10-21. DOI PubMed
PMC
15. Loomba RS, Flores S. Use of vasoactive agents in postoperative pediatric cardiac patients: insights from a national database. Congenit
Heart Dis 2019;14:1176-84. DOI PubMed
16. Lechner E, Hofer A, Leitner-Peneder G, et al. Levosimendan versus milrinone in neonates and infants after corrective open-heart
surgery: a pilot study. Pediatr Crit Care Med 2012;13:542-8. DOI PubMed
17. Momeni M, Rubay J, Matta A, et al. Levosimendan in congenital cardiac surgery: a randomized, double-blind clinical trial. J